INVO Fertility, Inc. (IVF)
NASDAQ: IVF · Real-Time Price · USD
1.510
+0.050 (3.42%)
At close: Jun 9, 2025, 4:00 PM
1.510
0.00 (0.00%)
Pre-market: Jun 10, 2025, 5:54 AM EDT
INVO Fertility Revenue
INVO Fertility had revenue of $1.64M in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to $6.59M. In the year 2024, INVO Fertility had annual revenue of $6.53M with 116.25% growth.
Revenue (ttm)
$6.59M
Revenue Growth
+116.25%
P/S Ratio
0.14
Revenue / Employee
$178,186
Employees
37
Market Cap
3.25M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 6.53M | 3.51M | 116.25% |
Dec 31, 2023 | 3.02M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionIVF News
- 13 days ago - INVO Fertility to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025 - GlobeNewsWire
- 20 days ago - INVO Fertility Announces First Quarter 2025 Financial Results - GlobeNewsWire
- 5 weeks ago - INVO Fertility Announces 2024 Financial Results with 116% Annual Revenue Growth and Further Improvements in Adjusted EBITDA - GlobeNewsWire
- 6 weeks ago - INVO Fertility Confirms New Nasdaq Trading Symbol of “IVF” - GlobeNewsWire
- 2 months ago - NAYA Biosciences Announces Strategic Decision to Separate Fertility and Oncology Businesses into Distinct Operations – Company Renamed “INVO Fertility, Inc.” - GlobeNewsWire
- 3 months ago - NAYA Announces a 1:12 Reverse Stock Split Effective Pre-Market Opening on March 18, 2025 - GlobeNewsWire
- 3 months ago - NAYA Biosciences Supports Recent Executive Order Aimed at Improving Access to Fertility Treatment - GlobeNewsWire
- 3 months ago - NAYA Biosciences Announces Nomination of New Board Members - GlobeNewsWire